By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over 12 months, SOPHiA GENETICS SA saw more selling than buying from its insiders — purchases of about $99,000 against sales of $5.1 million.
CARDOZA GEORGE (CFO) made the biggest buy, worth around $99,000. That includes C-suite money, which tends to get the most attention.
On the institutional side, 72 funds reported holding SOPH at the end of Q2 2026, and more funds bought than sold. Zooming out by quarter: 3 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
Are insiders buying or selling SOPH stock?
In the last 12 months SOPHiA GENETICS SA insiders made open-market purchases worth about $99,000 and sales worth about $5.1 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in SOPH?
The most recent open-market insider trade in SOPH was filed on 2026-10-07.
How many institutions own SOPH?
72 investment managers reported holding SOPH in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded SOPH?
No congressional trades in SOPH were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).